DK082690/DK/NIDDK NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2010	1
2011	5
2012	3
2013	8
2014	7
2015	2
2016	5
2017	3
2018	3
2020	1
2024	0

1

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

Weiss RH. Weiss RH. Semin Nephrol. 2018 Mar;38(2):175-182. doi: 10.1016/j.semnephrol.2018.01.006. Semin Nephrol. 2018. PMID: 29602399 Free PMC article. Review.

2

Translating L-2-HG to kidney cancer at the bench and bedside.

Aboud OA, Weiss RH. Aboud OA, et al. Ann Transl Med. 2018 Dec;6(Suppl 2):S103. doi: 10.21037/atm.2018.11.41. Ann Transl Med. 2018. PMID: 30740424 Free PMC article. No abstract available.

3

The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Hu SL, Chang A, Perazella MA, Okusa MD, Jaimes EA, Weiss RH; American Society of Nephrology Onco-Nephrology Forum. Hu SL, et al. J Am Soc Nephrol. 2016 Aug;27(8):2227-37. doi: 10.1681/ASN.2015121335. Epub 2016 Mar 9. J Am Soc Nephrol. 2016. PMID: 26961346 Free PMC article. Review.

4

Urine metabolomics for kidney cancer detection and biomarker discovery.

Ganti S, Weiss RH. Ganti S, et al. Urol Oncol. 2011 Sep-Oct;29(5):551-7. doi: 10.1016/j.urolonc.2011.05.013. Urol Oncol. 2011. PMID: 21930086 Free PMC article. Review.

5

Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets.

Wettersten HI, Weiss RH. Wettersten HI, et al. Organogenesis. 2013 Jan-Mar;9(1):11-8. doi: 10.4161/org.24322. Epub 2013 Jan 1. Organogenesis. 2013. PMID: 23538740 Free PMC article. Review.

6

Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis.

Trott JF, Hwang VJ, Ishimaru T, Chmiel KJ, Zhou JX, Shim K, Stewart BJ, Mahjoub MR, Jen KY, Barupal DK, Li X, Weiss RH. Trott JF, et al. Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1855-F1868. doi: 10.1152/ajprenal.00025.2018. Epub 2018 Oct 3. Am J Physiol Renal Physiol. 2018. PMID: 30280600 Free PMC article.

7

Anti-Cancer Activity of PAK4/NAMPT Inhibitor and Programmed Cell Death Protein-1 Antibody in Kidney Cancer.

Trott JF, Aboud OA, McLaughlin B, Anderson KL, Modiano JF, Kim K, Jen KY, Senapedis W, Chang H, Landesman Y, Baloglu E, Pili R, Weiss RH. Trott JF, et al. Kidney360. 2020 May 28;1(5):376-388. doi: 10.34067/kid.0000282019. Kidney360. 2020. PMID: 35224510 Free PMC article.

8

Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.

Abu Aboud O, Chen CH, Senapedis W, Baloglu E, Argueta C, Weiss RH. Abu Aboud O, et al. Mol Cancer Ther. 2016 Sep;15(9):2119-29. doi: 10.1158/1535-7163.MCT-16-0197. Epub 2016 Jul 7. Mol Cancer Ther. 2016. PMID: 27390344 Free PMC article.

9

Stability of miRNA in human urine supports its biomarker potential.

Mall C, Rocke DM, Durbin-Johnson B, Weiss RH. Mall C, et al. Biomark Med. 2013 Aug;7(4):623-31. doi: 10.2217/bmm.13.44. Biomark Med. 2013. PMID: 23905899 Free PMC article.

10

Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.

Kim J, Ulu A, Wan D, Yang J, Hammock BD, Weiss RH. Kim J, et al. Mol Cancer Ther. 2016 May;15(5):890-8. doi: 10.1158/1535-7163.MCT-15-0847. Epub 2016 Feb 26. Mol Cancer Ther. 2016. PMID: 26921392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year